ArticleClinical & translational immunology2026
Early brain-penetrant immunotherapy reverses interferon signature and improves motor outcome in a case of ADAR1-related Aicardi-Goutières syndrome.
Russell C Dale et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.